When to use model-informed drug development (Ep. 52)

About this episode

Nathan Teuscher shares his thoughts on model-informed drug development and its place in the development schedule.

This episode is a collection of my thoughts on model-informed drug development and where different modeling modalities fit into the development schedule. These are just my opinions and each development program is different. Links discussed in the show: You can connect with me on LinkedIn and send me a message Send me a message Sign up for my newsletter Copyright Teuscher Solutions LLC All Rights Reserved

People in this episode

Host: Nathan Teuscher

Topics covered

• model-informed drug development
• drug development schedule
• modeling modalities
• pharmacology
• clinical research

Keywords

• model-informed drug development
• drug development
• modeling modalities
• clinical pharmacology
• development program

Mentioned in this episode

Organizations: Teuscher Solutions LLC

More episodes of Clinical Pharmacology Podcast with Nathan Teuscher

• Bioequivalence Testing: The Stats Behind Generic Drug Approvals (Ep. 57) · May 25, 2026 · 24 min
• Examining Volume of Distribution (Ep. 56) · April 20, 2026 · 19 min
• Talking about data science with Mike Stackhouse (Ep. 55) · March 16, 2026 · 45 min
• Using Accelerator Mass Spectrometry in Clinical Pharmacology · February 16, 2026 · 38 min
• Using AI tools for regulatory intelligence (Ep. 53) · January 19, 2026 · 21 min
• QSP Modeling with Ahmed Elmokadem (Ep. 51) · November 24, 2025 · 45 min